About Celestial Biolabs Limited
Data last updated: 09 March 2026
Celestial Biolabs Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 19 November 1997, the company has been in operation for over 29 years.
Registered with ROC Hyderabad under CIN L72200TG1997PLC028374. Listed on BSE: 532871.
Capital: an authorised share capital of ₹29 Cr and a paid-up capital of ₹22.59 Cr. Formerly known as Celestial Labs Limited and Celestial Technologies Limited. It is led by directors including Amit Kumar Singh and Gangadharuni Durga Narasimha Kumar.
Last AGM: 23 May 2024. Financial statements filed for year ended 31 March 2023. Office: Plot No 82 Venkat Reddy Nagar Narapally Medchal – Malkajgiri Dist, Hyderabad, Telangana, India – 500039.
As per the financials filed for FY 2023, the company reported a revenue of ₹16.87 Lakh, a growth of 14% compared to the previous year.
The company has a workforce of approximately 1 employees as per the latest available data.
The company is associated with 2 brands - Celestial Biolabs, Celestia. As per MCA filings, the company has open charges of ₹21.1 Cr and satisfied charges of ₹8.9 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website celestialbiolabs.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressPlot No 82 Venkat Reddy Nagar Narapally Medchal – Malkajgiri Dist, Hyderabad, Telangana, India – 500039
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Celestial Biolabs Limited
Celestial Biolabs Limited has undergone 3 name changes throughout its history. The company was previously known as Celestial Labs Limited, Celestial Technologies Limited, and Celestial Technologies Private Limited. The current legal name is Celestial Biolabs Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Celestial Biolabs Limited | Current |
| Celestial Labs Limited | Previous |
| Celestial Technologies Limited | Previous |
| Celestial Technologies Private Limited | Previous |
CIN History of Celestial Biolabs Limited
Celestial Biolabs Limited has one previous CIN (Corporate Identification Number): L72200AP1997PLC028374. The current CIN is L72200TG1997PLC028374, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L72200TG1997PLC028374 | Current |
| L72200AP1997PLC028374 | Previous |
Associated Brands with Celestial Biolabs Limited
Celestial Biolabs Limited operates two associated brands: Celestial Biolabs and Celestia. These brands represent Celestial Biolabs Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of clinically validated biopharmaceutical products | celestialbiolabs.com | |
| Blockchain-based modular consensus and data network | celestia.org |
Competitors & Alternatives of Celestial Biolabs Limited
Brands and companies operating in the same space as Celestial Biolabs Limited include Binance, Mysten Labs, Solana and 3 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Binance
|
Online exchange platform for cryptocurrency | Ta Xbiex, Malta, Malta | 2017 |
Mysten Labs
|
Web3 infrastructure solutions are offered via a blockchain platform. | Palo Alto, United States, United States | 2021 |
Solana
|
Blockchain infrastructure for transactions and counting is provided by Solana. | San Francisco, United States, United States | 2010 |
O(1) Labs
|
Provider of a blockchain network | San Francisco, United States, United States | 2017 |
Ankr
|
Web3-native infrastructure for blockchain development and decentralization is provided. | San Francisco, United States, United States | 2017 |
Chain
|
Blockchain infrastructure is offered for financial application development. | San Francisco, United States, United States | 2014 |
Business Activity of Celestial Biolabs Limited
Celestial Biolabs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Celestial Biolabs Limited
Celestial Biolabs Limited is audited by M Surendra & Associates for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M Surendra & Associates | blur-value | blur-value | blur-value |
Board of Directors of Celestial Biolabs Limited
Celestial Biolabs Limited is currently managed by 6 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Amit Kumar Singh
Also directs:
Celestial Biolabs Limited
|
Managing Director | 28 Sep 2017 | 8 Years 9 Months | Current |
|
Gangadharuni Durga Narasimha Kumar
Also directs:
Celestial Biolabs Limited
|
Director | 02 Sep 2022 | 3 Years 10 Months | Current |
|
Rakle Mathur Nath
Also directs:
Celestial Biolabs Limited
|
Director | 02 Sep 2022 | 3 Years 10 Months | Current |
|
Prabhakar Korada
Also directs:
Celestial Biolabs Limited
|
Director | 02 Sep 2022 | 3 Years 10 Months | Current |
|
Padma Singh
Also directs:
Celestial Biolabs Limited
|
Director | 30 Sep 2005 | 20 Years 9 Months | Current |
Financials of Celestial Biolabs Limited FY 2023 filings available
Celestial Biolabs Limited reported revenue of ₹16.87 Lakh (up ) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2023 |
|---|---|
| Revenue from Operations | ₹16.87 Lakh |
| Other Income | ₹0 |
| Total Income | ₹16.87 Lakh |
| Cost of Materials Consumed | ₹10.61 Lakh |
| Purchases of Stock-in-Trade | ₹0 |
| Changes in Inventories | ₹0 |
| Employee Benefit Expense | ₹20.04 Lakh |
| Finance Costs | ₹83,000 |
| Depreciation & Amortisation | ₹2.83 Lakh |
| Other Expenses | ₹40.69 Lakh |
| Total Expenses | ₹75 Lakh |
| Profit Before Exceptional Items & Tax | -₹58.13 Lakh |
| Exceptional Items | ₹0 |
| Profit Before Tax | -₹58.13 Lakh |
| Total Tax Expense | ₹0 |
| Net Profit | -₹58.13 Lakh |
| attributable to Owners | ₹0 |
| attributable to NCI | ₹0 |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | -₹58.13 Lakh |
| EBITDA (computed) | -₹54.47 Lakh |
| Basic EPS | ₹-0.26 |
| Diluted EPS | ₹-0.26 |
| Metrics | FY 2023 |
|---|---|
| Total Assets | ₹17.24 Cr |
| Non-current Assets | ₹12.9 Cr |
| Current Assets | ₹4.34 Cr |
| Property, Plant & Equipment | ₹7.98 Lakh |
| Inventories | ₹3.38 Lakh |
| Trade Receivables | ₹3.71 Cr |
| Cash & Equivalents | ₹2.33 Lakh |
| Equity (Net Worth) | ₹2.77 Cr |
| Equity Share Capital | ₹22.59 Cr |
| Borrowings (Non-current) | ₹8.98 Cr |
| Borrowings (Current) | ₹3.05 Cr |
| Total Debt (computed) | ₹12.03 Cr |
| Current Liabilities | ₹5.49 Cr |
| Total Liabilities | ₹14.47 Cr |
| Metrics | FY 2023 |
|---|---|
| Operating Cash Flow | -₹35.53 Lakh |
| Investing Cash Flow | -₹93,000 |
| Financing Cash Flow | ₹38.68 Lakh |
| Capital Expenditure | ₹64,000 |
| Free Cash Flow (computed) | -₹36.17 Lakh |
| Dividends Paid | ₹0 |
| Net Change in Cash | ₹2.22 Lakh |
| Metrics | FY 2023 | FY 2022 |
|---|---|---|
| Revenue from Operations | ₹16.87 Lakh | ₹14.75 Lakh |
| Other Income | ₹0 | ₹0 |
| Total Income | ₹16.87 Lakh | ₹14.75 Lakh |
| Cost of Materials Consumed | ₹10.61 Lakh | ₹8.92 Lakh |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 |
| Employee Benefit Expense | ₹20.04 Lakh | ₹12.29 Lakh |
| Finance Costs | ₹23,000 | ₹0 |
| Depreciation & Amortisation | ₹2.83 Lakh | ₹3.02 Lakh |
| Other Expenses | ₹40.35 Lakh | ₹31.47 Lakh |
| Total Expenses | ₹74.06 Lakh | ₹55.7 Lakh |
| Profit Before Exceptional Items & Tax | -₹57.19 Lakh | -₹40.95 Lakh |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | -₹57.19 Lakh | -₹40.95 Lakh |
| Total Tax Expense | ₹0 | ₹0 |
| Net Profit | -₹57.19 Lakh | -₹40.95 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 |
| Total Comprehensive Income | -₹57.19 Lakh | -₹40.95 Lakh |
| EBITDA (computed) | -₹54.13 Lakh | -₹37.93 Lakh |
| Basic EPS | ₹-0.25 | ₹-0.18 |
| Diluted EPS | ₹-0.25 | ₹-0.18 |
| Metrics | FY 2023 | FY 2022 |
|---|---|---|
| Total Assets | ₹17.03 Cr | ₹17.18 Cr |
| Non-current Assets | ₹12.9 Cr | ₹12.92 Cr |
| Current Assets | ₹4.14 Cr | ₹4.26 Cr |
| Property, Plant & Equipment | ₹7.98 Lakh | ₹10.16 Lakh |
| Inventories | ₹3.38 Lakh | ₹4.88 Lakh |
| Trade Receivables | ₹3.71 Cr | ₹3.83 Cr |
| Cash & Equivalents | ₹1.71 Lakh | ₹13,000 |
| Equity (Net Worth) | ₹2.78 Cr | ₹3.35 Cr |
| Equity Share Capital | ₹22.59 Cr | ₹22.59 Cr |
| Borrowings (Non-current) | ₹8.86 Cr | ₹8.49 Cr |
| Borrowings (Current) | ₹3.05 Cr | ₹3.05 Cr |
| Total Debt (computed) | ₹11.91 Cr | ₹11.54 Cr |
| Current Liabilities | ₹5.4 Cr | ₹5.34 Cr |
| Total Liabilities | ₹14.26 Cr | ₹13.83 Cr |
| Metrics | FY 2023 | FY 2022 |
|---|---|---|
| Operating Cash Flow | -₹34.55 Lakh | -₹27.52 Lakh |
| Investing Cash Flow | -₹94,000 | -₹38,000 |
| Financing Cash Flow | ₹37.07 Lakh | ₹25.89 Lakh |
| Capital Expenditure | ₹65,000 | ₹0 |
| Free Cash Flow (computed) | -₹35.2 Lakh | -₹27.52 Lakh |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | ₹1.58 Lakh | -₹2.01 Lakh |
Shareholding Pattern of Celestial Biolabs Limited
As of FY 2022, Celestial Biolabs Limited's shareholding pattern shows 26.07% by promoters, 73.93% by public shareholders. Public shareholders hold the majority stake, reflecting broad public ownership.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Celestial Biolabs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2010 | State Bank of India | ₹20 Cr | Open |
| 16 Apr 2004 | State Bank of India | ₹1.1 Cr | Open |
| 28 Dec 2007 | 3I Infotech Trusteeship Services Limited | ₹8.25 Cr | Satisfied |
| 27 Jul 2006 | Technology Development Board | ₹49 Lakh | Satisfied |
| 08 Jun 1999 | State Bank of India | ₹12.9 Lakh | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Celestial Biolabs Limited
Celestial Biolabs Limited has a workforce of 1 employees as of Apr 05, 2024.
Employee Count & EPFO Data of Celestial Biolabs Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Celestial Biolabs Limited
GSTIN & GST Filing Data of Celestial Biolabs Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Celestial Biolabs Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Celestial Biolabs Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Celestial Biolabs Limited
MSME Payment Delays by Celestial Biolabs Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Celestial Biolabs Limited
Subsidiaries & Group Companies of Celestial Biolabs Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Celestial Biolabs Limited with ownership details.
MCA Filings & Documents of Celestial Biolabs Limited
MCA Filings & Documents of Celestial Biolabs Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Celestial Biolabs Limited
Frequently Asked Questions about Celestial Biolabs Limited
Celestial Biolabs Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 19 November 1997 (29+ years old) and is registered under CIN L72200TG1997PLC028374. Listed on BSE: 532871. The company has 1 employees.
Celestial Biolabs Limited reported revenue of ₹16.87 Lakh for FY 2023 (up 14.00% YoY).
The current directors of Celestial Biolabs Limited are:
- Amit Kumar Singh
- Gangadharuni Durga Narasimha Kumar
- Rakle Mathur Nath
- Arvind Deviprasad Sharma
- Prabhakar Korada
- Padma Singh
The primary industry of Celestial Biolabs Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Celestial Biolabs Limited is listed on BSE with code 532871.
Celestial Biolabs Limited can be reached at the registered office: Plot No 82 Venkat Reddy Nagar Narapally Medchal – Malkajgiri Dist, Hyderabad, Telangana, India – 500039, or through the website celestialbiolabs.com.